Quantbot Technologies LP Blueprint Medicines Corp Transaction History

Quantbot Technologies LP

$2.5 Billion
Q4 2024

A detailed history of Quantbot Technologies LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Quantbot Technologies LP holds 76 shares of BPMC stock, worth $6,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1,164 93.47%

Holding current value

$6,742

Previous $107,000 94.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$82.48 - $101.39 $89,738 - $110,312	-1,088 Reduced 93.47%	76 $6,000
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $97,892 - $140,262	1,164 New	1,164 $107,000
Q2 2022 Aug 09, 2022	SELL	$45.23 - $70.15 $67,845 - $105,225	-1,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $81,150 - $165,120	1,500 New	1,500 $95,000
Q3 2021 Nov 09, 2021	SELL	$80.98 - $109.47 $63,407 - $85,715	-783 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$82.78 - $101.0 $64,816 - $79,083	783 New	783 $68,000
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $55,248 - $74,688	-600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $28,241 - $39,397	-425 Reduced 41.46%	600 $55,000
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $43,217 - $60,007	757 Added 282.46%	1,025 $79,000
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $30,405 - $51,963	-632 Reduced 70.22%	268 $15,000
Q4 2019 Feb 10, 2020	BUY	$66.73 - $82.59 $26,692 - $33,036	400 Added 80.0%	900 $72,000
Q3 2019 Nov 12, 2019	SELL	$72.9 - $101.41 $21,870 - $30,423	-300 Reduced 37.5%	500 $36,000
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $58,832 - $78,240	800 New	800 $75,000
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $34,086 - $55,546	-748 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $44,064 - $58,583	748 New	748 $58,000
Q2 2018 Aug 13, 2018	SELL	$60.96 - $101.18 $20,360 - $33,794	-334 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$73.28 - $102.95 $117,980 - $165,749	-1,610 Reduced 82.82%	334 $30,000
Q4 2017 Feb 12, 2018	BUY	$62.91 - $88.32 $118,899 - $166,924	1,890 Added 3500.0%	1,944 $146,000
Q3 2017 Nov 07, 2017	BUY	$42.37 - $69.67 $2,287 - $3,762	54	54 $3,000

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.3B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Blueprint Medicines Corp Transaction History